Canadapms‑MOXIFLOXACIN HCL 0.5% ophthalmic solution (Market Authorization DIN 02432218), lot 240518, sold in 3 mL by Pharmascience is affected. The lot was recalled because the assay is out of trend; owners should verify if their product is the affected lot, consult their healthcare provider before discontinuing use, contact the recalling firm with questions, and report any side effects or other safety complaints to Health Canada.
What's being recalled
Depth of Recall: Wholesalers & Retailers
Companies: Pharmascience, 6111 avenue Royalmount, suite 100, Montréal QC, H4P 2T4.
How to identify it
Product Name: pms-MOXIFLOXACIN; Market Authorization: DIN 02432218; Dosage Form: Ophthalmic solution; Strength: MOXIFLOXACIN HYDROCHLORIDE 0.5%; Lot number: 240518
The hazard
The assay is out of trend in the affected lot.
What to do
Verify if your product is affected.
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Contact the recalling firm if you have any questions about the recall.
Report any health product related side effects to Health Canada.
Report any other health product safety complaints to Health Canada.
Where it was sold
National
The official notice
This page is a summary of the notice published by Health Canada, collected from Health Canada, CFIA and Transport Canada. Check the original before you act on it.
Read the official notice (opens in a new tab)